• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AV-TEMECULA-CT XIENCE PRIME LL EVEROLIMUS ELUTING CORONARY STENT SYSTEM; DRUG ELUTING CORONARY STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AV-TEMECULA-CT XIENCE PRIME LL EVEROLIMUS ELUTING CORONARY STENT SYSTEM; DRUG ELUTING CORONARY STENT SYSTEM Back to Search Results
Catalog Number 1011707-33
Device Problems Difficult or Delayed Positioning (1157); Leak/Splash (1354); Improper or Incorrect Procedure or Method (2017)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 05/15/2018
Event Type  Injury  
Manufacturer Narrative
(b)(4).The device is expected to be returned for evaluation.It has not yet been received.A follow up report will be submitted with all relevant information.
 
Event Description
It was reported that the procedure was performed to treat a 90% stenosed proximal left anterior descending (lad) coronary artery with no tortuosity and no calcification.Pre-dilatation was performed using a 2.00x15mm nc traveler balloon dilatation catheter (bdc).A 2.5x33mm xience prime rx stent delivery system (sds) was advanced to the lesion without resistance.During sds inflation, it was noted that the indeflator lost pressure.The initial indeflator was replaced, and the replacement indeflator also lost pressure.The balloon did not inflate properly and the stent did not fully expand due to a hole/leakage located on the shaft approximately 20 centimeters from the balloon.It was further reported that the sds had not been prepped outside the patient prior to use.Subsequently, a bdc was advanced to the lesion and successfully expanded the stent.There was no adverse patient effect and no reported clinically significant delay in the procedure.Subsequently, a bdc was advanced to the lesion and successfully expanded the stent.There was no adverse patient effect and no reported clinically significant delay in the procedure.No additional information was provided.
 
Manufacturer Narrative
(b)(4).It was initially reported that the device would be returned for analysis.Subsequent information revealed that the device was discarded and is not available for evaluation.The device was not returned for analysis.The investigation was unable to determine a conclusive cause for the reported shaft leak; however, the reported difficulty to deploy appears to be related to circumstances of the procedure as it is likely the shaft leak prevented the device balloon from fully inflating causing the reported difficulty to deploy.Additionally, the device was prepped inside the anatomy prior to the reported difficulties.It should be noted that the xience prime everolimus eluting coronary stent system, instructions for use (ifu) lists that the preparation is to be performed prior delivery procedure.In this case, it is unknown if the ifu deviation related contributed to the reported leak and difficulty to deploy.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history identified no similar incidents from this lot.There is no indication of a product quality issue with respect to manufacture, design or labeling of the device.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
XIENCE PRIME LL EVEROLIMUS ELUTING CORONARY STENT SYSTEM
Type of Device
DRUG ELUTING CORONARY STENT SYSTEM
Manufacturer (Section D)
AV-TEMECULA-CT
abbott vascular
26531 ynez road
temecula CA 92591 4628
Manufacturer (Section G)
CLONMEL, IRELAND REG# 9616693
abbott vascular
26531 ynez road
temecula CA 92591 4628
Manufacturer Contact
connie speck
abbott vascular
26531 ynez road
temecula, CA 92591-4628
9519143996
MDR Report Key7587862
MDR Text Key110642515
Report Number2024168-2018-04366
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)N
Reporter Country CodeIN
PMA/PMN Number
P110019
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,distri
Reporter Occupation Physician
Remedial Action Other
Type of Report Initial,Followup
Report Date 07/27/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date05/15/2020
Device Catalogue Number1011707-33
Device Lot Number7050841
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 05/18/2018
Initial Date FDA Received06/11/2018
Supplement Dates Manufacturer Received07/24/2018
Supplement Dates FDA Received07/27/2018
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured05/01/2017
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-